Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
CDX2 marker as immunohistochemistry stain was positive as brown color... | Download Scientific Diagram
CDX2 - an overview | ScienceDirect Topics
Examples of CDX2 expression. a Positive nuclear CDX2 expression in all... | Download Scientific Diagram
Cdx1 and Cdx2 Function as Tumor Suppressors - Journal of Biological Chemistry
Genes | Free Full-Text | Cdx2 Animal Models Reveal Developmental Origins of Cancers | HTML
Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer - Weimin Xu, Yilian Zhu, Wei Shen, Wenjun Ding, Tingyu Wu, Yuegui Guo, Xiaobing Chen, Mingxia Zhou, Yingwei Chen,
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site | HTML
Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site. - Abstract - Europe PMC
Gastric-immunophenotype tumour end with CDX2 expression. Tumour cells... | Download Scientific Diagram
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer - Bruun - 2018 - Molecular Oncology - Wiley Online Library
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report | SpringerLink
CDX2, CK7 and CK20 staining in distant metastases of | Download Table
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas | Modern Pathology
Cdx2 Protein Expression in Normal and Malignant Human Tissues: An Immunohistochemical Survey Using Tissue Microarrays | Modern Pathology
Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: a pathological, clinical and outcome study - Kmeid - 2021 - Histopathology - Wiley Online Library
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer | NEJM
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
CDX1 and CDX2 immunohistochemistry and image analysis at different... | Download Scientific Diagram
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer - European Journal of Cancer
